Jane Street’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-19,233
Closed -$167K 10343
2022
Q4
$167K Sell
19,233
-4,676
-20% -$37.6K ﹤0.01% 7800
2022
Q3
$143K Sell
23,909
-2,213
-8% -$12K ﹤0.01% 8441
2022
Q2
$141K Sell
26,122
-30
-0.1% -$162 ﹤0.01% 8447
2022
Q1
$123K Sell
26,152
-3,647
-12% -$19.1K ﹤0.01% 9354
2021
Q4
$146K Sell
29,799
-21,057
-41% -$104K ﹤0.01% 9021
2021
Q3
$393K Sell
50,856
-3,398
-6% -$29.1K ﹤0.01% 7710
2021
Q2
$633K Buy
+54,254
New +$824K ﹤0.01% 6803

Other funds holding VECT

Jane Street's VECT Position: Q1 2023 in Review

Jane Street sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q1 2023, closing a stake of 19,233 shares — an estimated $167K sold.

Jane Street first reported a position in VECT in Q2 2021 and held it in 7 quarters. The position peaked at $633K in Q2 2021. 35 funds tracked by Wall St. Rank hold VECT as of Q1 2023.

  • Jane Street reported no remaining VectivBio Holding AG Ordinary Shares position as of Q1 2023 after selling out during the quarter.
  • Jane Street sold 19,233 VectivBio Holding AG Ordinary Shares shares in Q1 2023, an estimated $167K.
  • Jane Street first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 7 quarters.
  • Jane Street's VectivBio Holding AG Ordinary Shares position peaked at $633K in Q2 2021.
  • 35 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q1 2023.

Based on Jane Street's 13F filing for Q1 2023, filed 16 May 2023.